Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03289039 |
| Title | Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer |
| Recruitment | Terminated |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Dana-Farber Cancer Institute |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Indiana University | Indianapolis | Indiana | 46202 | United States | Details | |
| Eastern Maine Medical Center | Brewer | Maine | 04412 | United States | Details | |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02115 | United States | Details | |
| Dana-Farber/New Hampshire Oncology-Hematology | Londonderry | New Hampshire | 03053 | United States | Details | |
| The Ohio State University | Columbus | Ohio | 43210 | United States | Details | |
| UT Southwestern | Dallas | Texas | 75390 | United States | Details |